Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?

INTRODUCTION: Cerebrospinal fluid (CSF) neurodegenerative markers are measured clinically to support a diagnosis of Alzheimer's disease. Several preanalytical factors may alter the CSF concentrations of amyloid β 1–42 (Aβ1–42) in particular with the potential to influence diagnosis. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterson, Ross W., Toombs, Jamie, Chapman, Miles D., Nicholas, Jennifer M., Heslegrave, Amanda J., Slattery, Catherine F., Foulkes, Alexander J.M., Clark, Camilla N., Lane, Christopher A.S., Weston, Philip S.J., Lunn, Michael P., Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
CSF Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877931/
https://www.ncbi.nlm.nih.gov/pubmed/27239518
http://dx.doi.org/10.1016/j.dadm.2015.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877931/
https://www.ncbi.nlm.nih.gov/pubmed/27239518
http://dx.doi.org/10.1016/j.dadm.2015.06.003

Ejemplares similares